GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Level Biotechnology Inc (ROCO:3118) » Definitions » EV-to-Revenue

Level Biotechnology (ROCO:3118) EV-to-Revenue : 1.00 (As of Jun. 05, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Level Biotechnology EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Level Biotechnology's enterprise value is NT$696.6 Mil. Level Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$694.8 Mil. Therefore, Level Biotechnology's EV-to-Revenue for today is 1.00.

The historical rank and industry rank for Level Biotechnology's EV-to-Revenue or its related term are showing as below:

ROCO:3118' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.6   Med: 1.2   Max: 2.53
Current: 1

During the past 13 years, the highest EV-to-Revenue of Level Biotechnology was 2.53. The lowest was 0.60. And the median was 1.20.

ROCO:3118's EV-to-Revenue is ranked better than
87.76% of 1038 companies
in the Biotechnology industry
Industry Median: 7.985 vs ROCO:3118: 1.00

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-05), Level Biotechnology's stock price is NT$35.35. Level Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$21.28. Therefore, Level Biotechnology's PS Ratio for today is 1.66.


Level Biotechnology EV-to-Revenue Historical Data

The historical data trend for Level Biotechnology's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Biotechnology EV-to-Revenue Chart

Level Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.90 0.76 0.75 0.81

Level Biotechnology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.82 0.87 0.81 0.81

Competitive Comparison of Level Biotechnology's EV-to-Revenue

For the Biotechnology subindustry, Level Biotechnology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Biotechnology's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Level Biotechnology's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Level Biotechnology's EV-to-Revenue falls into.



Level Biotechnology EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Level Biotechnology's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=696.644/694.795
=1.00

Level Biotechnology's current Enterprise Value is NT$696.6 Mil.
Level Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$694.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Biotechnology  (ROCO:3118) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Level Biotechnology's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=35.35/21.275
=1.66

Level Biotechnology's share price for today is NT$35.35.
Level Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$21.28.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Biotechnology EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Level Biotechnology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Biotechnology (ROCO:3118) Business Description

Traded in Other Exchanges
N/A
Address
No.80, Lane 169, Kangning Street, Hsi-Chih, New Taipei, TWN, 221
Level Biotechnology Inc is a Taiwan based company engages in the provision of biotechnological services. It offers cell culture, immune protein, gene nucleic acids, and molecular biology, and instruments and equipment. It offers preclinical trial services in the areas of mammalian toxicology, genetic toxicology, pharmacology, biocompatibility, and model animal production.

Level Biotechnology (ROCO:3118) Headlines

No Headlines